Armistice Capital »

Hyatt Hotels Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Hyatt Hotels Corporation (H) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Hyatt Hotels Corporation

Tip: Access up to 7 years of quarterly data

All positions including Hyatt Hotels Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hyatt Hotels Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 17k 143.79
2025-09-30 $7.7M 54k 141.93

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Hyatt Hotels Corporation

Bamco
Principal Financial Group
Wellington Management Company
BlackRock
Vanguard Group
Massachusetts Financial Services
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Morgan Stanley
Veritas Asset Management
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Bank of America Corporation

View all funds holding Hyatt Hotels Corporation